The role of 11-oxygenated androgens in prostate cancer
11-oxygenated androgens are a class of steroids capable of activating the androgen receptor (AR) at physiologically relevant concentrations. In view of the AR as a key driver of prostate cancer (PC), these steroids are potential drivers of disease and progression. The 11-oxygenated androgens are adr...
Main Authors: | Gido Snaterse, Johannes Hofland, Bruno Lapauw |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2023-04-01
|
Series: | Endocrine Oncology |
Subjects: | |
Online Access: | https://eo.bioscientifica.com/view/journals/eo/3/1/EO-22-0072.xml |
Similar Items
-
Titration of Androgen Signaling: How Basic Studies Have Informed Clinical Trials Using High-Dose Testosterone Therapy in Castrate-Resistant Prostate Cancer
by: Steven K. Nordeen, et al.
Published: (2021-08-01) -
Androgens and prostate disease
by: Lori A Cooper, et al.
Published: (2014-04-01) -
Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer
by: Jin Wook Kim
Published: (2020-05-01) -
Androgen receptor and prostate cancer
by: Karen E. Livermore, et al.
Published: (2016-06-01) -
Physiological normal levels of androgen inhibit proliferation of prostate cancer cells in vitro
by: Weitao Song, et al.
Published: (2014-12-01)